High levels of antibody molecule linked to increased rates of death from all diseases
Mayo Clinic researchers have identified an immune system deficiency whose presence shows someone is up to four times likelier to die than a person without it. The glitch involves an antibody molecule called a free light chain; people whose immune systems produce too much of the molecule are far more likely to die of a life-threatening illness such as cancer, diabetes and cardiac and respiratory disease than those whose bodies make normal levels. The study is published in the June issue of Mayo Clinic Proceedings.
Please login or register to Read Full Article
04 June 2012
CTI acquires world-wide rights to S*BIO’s pacritinib
Cell Therapeutics, Inc., announced today that it has completed its acquisition gaining world-wide rights to S*BIO Pte Ltd.'s pacritinib.
Please login or register to Read Full Article
03 June 2012
ImmunoGen reports data from T-DM1 Phase III trial on HER2-positive metastatic breast cancer
ImmunoGen, Inc., a biotechnology company with a proprietary Targeted Antibody Payload (TAP) technology, today announced results from the trastuzumab emtansine Phase III EMILIA trial conducted by Roche.
Please login or register to Read Full Article
03 June 2012
Many men with metastatic prostate cancer live longer on continuous hormone therapy
Many men with metastatic, hormone-sensitive prostate cancer live longer on continuous androgen-deprivation therapy (also known as hormone therapy) than on intermittent therapy, according to a seventeen-year study led by SWOG, a cancer research cooperative group funded by the National Cancer Institute (NCI).
Please login or register to Read Full Article
03 June 2012
Positive results from Auxilium’s XIAFLEX phase III studies on Peyronie's disease
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line results from its IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials, the phase III studies that assessed XIAFLEX (collagenase clostridium histolyticum or CCH), a novel, in-office, first-in-class biologic therapy for the potential treatment of Peyronie's disease (PD).
Please login or register to Read Full Article
03 June 2012
Study shows valuable role of Mammostrat in assessing ER+ postmenopausal breast cancer patients
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.
Please login or register to Read Full Article
03 June 2012
Duloxetine drug reduces painful chemotherapy-induced peripheral neuropathy in majority of patients
The antidepressant drug duloxetine, known commercially as Cymbalta, helped relieve painful tingling feelings caused by chemotherapy in 59 percent of patients, a new study finds. This is the first clinical trial to find an effective treatment for this pain.
Please login or register to Read Full Article
03 June 2012
RMHCSC awards $328,000 in scholarship funds to Southland high school seniors
Today, Ronald McDonald House Charities of Southern California (RMHCSC) awarded $328,000 in scholarship funds to exceptional high school seniors who reside in Los Angeles, Orange, Riverside, San Bernardino and Ventura counties.
Please login or register to Read Full Article
03 June 2012
Results from Puma’s PB272 Phase I combination trial on metastatic HER-2 positive breast cancer
Puma Biotechnology, Inc., a development stage biopharmaceutical company, announced that results from an ongoing Phase I clinical trial of its lead drug candidate PB272 (neratinib) given in combination with the anticancer drugs paclitaxel and trastuzumab in patients with metastatic HER-2 positive breast cancer were presented in a poster presentation at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting.
Please login or register to Read Full Article
03 June 2012
-
Health
Tainted Peanut Butter May Be Source of National Salmonella Outbreak
-
Nursing
Volunteer Nurses Ready to Assist During Inauguration
-
Pharmacy
FDA investigating asthma medications
-
Interview
ENTERTAINMENT NEWS: DESPERATE HOUSEWIVES TAKES UNNECESSARY SWIPE AT FILIPINO MEDICINE
-
Dermotology
RegeneRx Reports Phase II Pressure Ulcer Trial Results
-
Sports
-
Business
-
Cosmetic
-
Research
Medical Search
Login
Who's Online
We have 114 guests onlinePolls
Medical Blog Directory
